SHC
Sotera Health Co
18.10$
+1.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 17.1% | 17.8% | 15.9% | 16.3% | 17.9% | 17.1% | 17.9% | 18.9% | 18.1% | 18.8% | 18.1% | 19.5% | |
| 8.1% | 9.5% | 8.5% | 8.0% | 9.7% | 9.0% | 9.8% | 10.3% | 9.4% | 10.6% | 9.8% | 10.8% | |
| 8.1% | 9.5% | 8.5% | 8.0% | 9.7% | 9.0% | 9.8% | 10.3% | 9.4% | 10.6% | 9.8% | 10.8% | |
| 5.8% | 5.6% | 4.6% | 5.3% | 5.6% | 5.4% | 4.9% | 5.6% | 6.1% | 5.4% | 5.4% | 6.0% | |
| 1.2% | 1.5% | 1.7% | 1.9% | 1.7% | 1.6% | 2.0% | 1.9% | 1.7% | 1.8% | 1.9% | 1.9% | |
| 36.3% | 35.5% | 36.0% | 35.9% | 35.1% | 35.2% | 35.0% | 34.3% | 34.5% | 33.8% | 33.9% | 33.0% | |
| 14.1% | 13.3% | 12.8% | 12.0% | 11.2% | 10.3% | 9.7% | 9.3% | 9.1% | 8.8% | 8.6% | 8.2% | |
| 87.6% | 85.8% | 86.0% | 86.2% | 85.1% | 86.8% | 86.6% | 84.1% | 82.7% | 81.4% | 80.8% | 79.9% | |
| 6.6% | 7.4% | 5.0% | 5.5% | 6.2% | 6.2% | 7.3% | 7.7% | 7.6% | 7.6% | 6.4% | 7.0% | |
| 0.7% | 0.6% | 0.4% | 0.6% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | |
| 1.9% | 2.3% | 2.0% | 2.1% | 2.2% | 1.8% | 2.3% | 2.0% | 1.9% | 2.4% | 2.4% | 3.1% | |
| 73.2% | 71.0% | 72.7% | 72.4% | 70.2% | 71.9% | 71.2% | 68.5% | 66.8% | 65.2% | 65.6% | 64.3% | |
| 12.4% | 14.2% | 14.0% | 13.8% | 14.9% | 13.2% | 13.4% | 15.9% | 17.3% | 18.6% | 19.2% | 20.1% | |
| -22.8% | -20.9% | -21.2% | -20.9% | -19.8% | -19.9% | -20.1% | -19.1% | -17.8% | -16.3% | -15.6% | -13.7% | |
| 9.3% | 9.1% | 9.3% | 9.3% | 9.1% | 9.3% | 9.2% | 8.9% | 9.0% | 8.8% | 8.9% | 8.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.